A Pokemon Mobile Game You Might Want to Try

A Pokemon Mobile Game You Might Want to Try

‘Hey Monster' is the Pokemon game we needed for our smartphones'

Consumer Discretionary

Tesla Motors, Inc. (NASDAQ:TSLA) - SolarCity Corp (NASDAQ:SCTY) Get Ready for Friday's Event with Solar Roof

SolarCity will try to attract institutional shareholders to approve the merger by showing off its latest product

Tesla Motors Battery Swap All Set to Make a Comeback

The battery swap will help Tesla in meeting the charging demand once Model 3 and Tesla Semi are out

Wedbush Positive on Amazon.com, Inc. (AMZN) Ahead of Q3 Earnings

Wedbush reiterates an Outperform rating on Amazon heading into 3Q results

Tesla Motors, Inc. (NASDAQ:TSLA) to Change Financial Reporting Method

Tesla is expected to report financials on a GAAP basis, prompting Oppenheimer to update its model

Here's Why Freeport-McMoRan Inc (NYSE:FCX) Misses Consensus estimates in Q3

We keep tabs on Amazon’s financial performance in the third quarter

Tesla Motors Inc (TSLA) Ranked in List of Least Reliable Cars

Tesla was ranked at No.25 out of the 29 brands due to the problems of Model X SUV by Consumer Reports


UBS Investigates if Apple Can Maintain its Product Differentiation

Does Apple have the ability to revert focus on "user experience" than hardware?

Apple Inc.'s (NASDAQ:AAPL) ASP Boost Doesn't Pacify iPhone 7 Cycle Concerns: Oppenheimer

Oppenheimer restates its 'Perform' rating on Apple, saying ASP boost wouldn’t ease concerns with iPhone 7 cycle

WhatsApp is Finally Rolling Out Video Calling On Android

A phased beta rollout has begun for the video calling feature on WhatsApp

Apple Inc. (NASDAQ:AAPL) Still The Best Smartwatch Vendor Despite Downfall Of Wearable Market

Smartwatch shipments have experienced a downfall of more than 50 percent during its third quarter

How To Install Android 7.0 Nougat On The LG Nexus 5

Now you can enjoy Android 7.0 Nougat on your Nexus 5

Twitter Inc (NYSE:TWTR) : Bank of America Corp (NYSE:BAC) Remains Skeptical Ahead of Earnings

Analyst Justin Post discussed the company’s weakening position in his recent thesis, while he continued that there are few developments that might not go in its favor


RBC Capital Markets Upgrades Chesapeake Energy Corporation

RBC Capital Markets analyst believes that Chesapeake's lower cost structure and improved margin outlook over the next few years highlighted in the recently held analyst day deserves an applaud

Chevron Corporation (NYSE:CVX) - Is Investment in Richmond The Right Move?

With the thicket of fossil fuel regulations in California, would the energy giant benefit from the Richmond refinery renovation?

Chesapeake Energy Corporation (CHK) - Positive Sentiment on the Company's Stock Ahead of Analyst Day

Although several financial and operational challenges stand in the company’s way to success, the appreciable progress made over the past few years and in particular, the financial overhaul in 2016 under a challenging commodity price environment signals good times ahead for the company

Petroleo Brasileiro SA Petrobras (ADR) (PBR) Agrees To Settle Lawsuits Over Corruption Scheme For The First Time Ever

The state owned company has agreed to settle lawsuits from Pacific Investment Management Co. along with three other investors that were reportedly harmed by the corruption scandal

Petroleo Brasileiro (PBR): Deleveraging Tactics Leads to Credit Rating Upgrade by Moody's

We take a look at the reasons behind Moody’s decision to upgrade Petrobras’ credit rating


Merck & Co., Inc. (MRK) Surges on Q3 Beat & Major Keytruda Win

The Food and Drug Administration cleared Keytruda for use in previously untreated lung cancer patients

Gilead Sciences, Inc.'s (NASDAQ:GILD) NASH Data Impressive & Underappreciated: Leerink

Leerink Partners analyst raised price target on Gilead stock based on NASH data feedback from an expert

GlaxoSmithKline plc (ADR) (GSK) Q3 Earnings: What Merrill Lynch Expects

GlaxoSmithKline is due to report third quarter earnings on Wednesday

Valeant Pharmaceuticals Intl Inc. (VRX) Shares Are Poised On Disappointing

The company seems to be better at raising prices of its drugs, rather than boosting its stock price

Senators Frown on Mylan NV (MYL) EpiPen Settlement with DOJ, Shares Drop

Mylan's shares continue taking a beat as the EpiPen controversy is not abating